Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
about
Emerging roles of Nrf2 signal in non-small cell lung cancerCytoprotection "gone astray": Nrf2 and its role in cancerSirtuin activation: a role for plasma membrane in the cell growth puzzleβ,β-Dimethylacrylshikonin sensitizes human colon cancer cells to ionizing radiation through the upregulation of reactive oxygen species.Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomasMiR-28 regulates Nrf2 expression through a Keap1-independent mechanismNRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity.Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cellsTrianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.Anti-cancer natural products isolated from chinese medicinal herbsTargeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancerSIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancermiR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.LOSS of Mrp1 alters detoxification enzyme expression in a tissue- and hormonal-status-specific manner.Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health.New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease preventionDifferential regulation of detoxification enzymes in hepatic and mammary tissue by hops (Humulus lupulus) in vitro and in vivo.Nrf2: bane or blessing in cancer?Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation.Cabbage Juices and Indoles Modulate the Expression Profile of AhR, ERα, and Nrf2 in Human Breast Cell Lines.Shikonin protects dopaminergic cell line PC12 against 6-hydroxydopamine-mediated neurotoxicity via both glutathione-dependent and independent pathways and by inhibiting apoptosis.Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells.Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.Natural Products for the Management and Prevention of Breast Cancer.Transcriptional regulation of brain gene expression in response to a territorial intrusion.SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and ProgressionActivation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor
P2860
Q28078928-EB660ACF-4384-4014-96E5-DBAAFD03BDF0Q28393784-AE568B26-BCE6-493E-9236-079B62B66C66Q33354469-7E415939-8682-4AD4-9059-E56C86F577CEQ33727813-24003593-A736-490E-B47E-9043780ED91CQ33938619-2D175844-EB56-4B7D-B2E8-AF7F9666BCE5Q34189586-64ACE4D7-5B40-411F-AE97-688DBE292B96Q34467592-C306D4E8-BA72-442B-9974-80F169EEFFEDQ35048199-7C58DC4E-4590-4A1A-B627-3A85EE83366DQ35138880-AABBA69B-DD8B-4BA9-94DF-B1C0E1DE3893Q35143916-B9686158-CBE2-424E-BB3A-039A3A07031CQ35269645-FB5240DF-2345-4DB0-8F00-3896056B3673Q35501899-3FE03872-0038-4A2D-8C94-A122F35344E8Q35562532-0F52D2E8-971B-46CB-AD6D-3668E0C93440Q36031004-7D183634-E9DA-456C-AB12-9543B8970543Q36293908-0B4B20D6-1DE4-417C-A508-76A560AE80E4Q36548027-CD7611D1-AAEF-4E83-900C-F929F0BA1951Q37058949-FA4A9BFA-A4A9-4485-BCC4-04139664B07FQ37283111-77CE5B44-B3A3-4822-B201-4E095E4EBDC5Q37300127-6E2C3799-1DF3-4D2E-B914-CD061827E71DQ37340750-EA455EE5-38CD-400A-973C-F734943B7CE5Q37396313-9BD7E624-C9D6-48C7-8937-8C2E8C545571Q38193757-9D259751-000F-401F-B162-2C486AEFB425Q38632920-1030A897-6232-4C9C-968E-A71158BDF66CQ38833096-B063CFCE-CE6A-4B8C-BE9E-A4F172F966E9Q39157576-A217D013-CA23-495F-840E-AE7D93B687D5Q39481964-390B6E8A-5AE0-4873-8CC9-DD7373B237A0Q47560186-A5EF607E-9D56-49A8-86BA-C07E835E5187Q55043805-3E4A23F1-A2B4-4444-83FF-C8BBEDCE8CE2Q55331821-EC8C5403-F2EF-44C5-B7E6-EA1FBA0EDE54Q57490805-6F85A447-68D5-482D-8850-1E3A3F37608BQ58775167-CDFF6D9A-9482-4DC1-AE3A-D177AD300593
P2860
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@ast
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@en
type
label
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@ast
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@en
prefLabel
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@ast
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@en
P2093
P2860
P1476
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
@en
P2093
Angela M H Brodie
Nancy E Davidson
Thomas W Kensler
P2860
P2888
P304
P356
10.1007/S10549-010-1023-8
P407
P577
2010-07-10T00:00:00Z